These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
627 related items for PubMed ID: 9726648
1. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats. Wlaź P, Ebert U, Potschka H, Löscher W. Eur J Pharmacol; 1998 Jul 24; 353(2-3):177-89. PubMed ID: 9726648 [Abstract] [Full Text] [Related]
2. Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats. Potschka H, Fedrowitz M, Löscher W. Eur J Pharmacol; 1999 Jun 18; 374(2):175-87. PubMed ID: 10422758 [Abstract] [Full Text] [Related]
3. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors. Löscher W, Hönack D. J Pharmacol Exp Ther; 1991 Jun 18; 257(3):1146-53. PubMed ID: 1675288 [Abstract] [Full Text] [Related]
4. Corneal kindling in mice: behavioral and pharmacological differences to conventional kindling. Potschka H, Löscher W. Epilepsy Res; 1999 Nov 18; 37(2):109-20. PubMed ID: 10510977 [Abstract] [Full Text] [Related]
7. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Löscher W, Wlaź P, Rundfeldt C, Baran H, Hönack D. Br J Pharmacol; 1994 May 18; 112(1):97-106. PubMed ID: 8032669 [Abstract] [Full Text] [Related]
9. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Wlaź P, Ebert U, Löscher W. Eur J Neurosci; 1994 Nov 01; 6(11):1710-9. PubMed ID: 7874310 [Abstract] [Full Text] [Related]
11. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Bespalov A, Dravolina O, Belozertseva I, Adamcio B, Zvartau E. Behav Pharmacol; 2006 Jun 01; 17(4):295-302. PubMed ID: 16914947 [Abstract] [Full Text] [Related]
16. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Chaperon F, Müller W, Auberson YP, Tricklebank MD, Neijt HC. Behav Pharmacol; 2003 Sep 01; 14(5-6):477-87. PubMed ID: 14501261 [Abstract] [Full Text] [Related]
17. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Löscher W, Rundfeldt C, Hönack D. Eur J Neurosci; 1993 Nov 01; 5(11):1545-50. PubMed ID: 7904524 [Abstract] [Full Text] [Related]
18. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Marcus MM, Mathé JM, Nomikos GG, Svensson TH. Neuropharmacology; 2001 Mar 01; 40(4):482-90. PubMed ID: 11249957 [Abstract] [Full Text] [Related]